Journal
JOURNAL OF CANCER SURVIVORSHIP
Volume 17, Issue 5, Pages 1471-1479Publisher
SPRINGER
DOI: 10.1007/s11764-022-01178-z
Keywords
Follow-up; Surveillance; Breast cancer; Shared decision-making; Risk information; Personalised care
Categories
Ask authors/readers for more resources
This study explored the experiences of breast cancer patients with information provision and decision-making about post-treatment surveillance. Although there was a desire for shared decision-making, participants did not experience it. Information provision was suboptimal and unstructured. Participants were hesitant towards less intensive surveillance, but open to the use of personalised risk assessment.
Purpose In this study, we explored how patients experience current information provision and decision-making about post-treatment surveillance after breast cancer. Furthermore, we assessed patients' perspectives regarding less intensive surveillance in case of a low risk of recurrence. Methods We conducted semi-structured interviews with 22 women in the post-treatment surveillance trajectory in seven Dutch teaching hospitals. Results Although the majority of participants indicated a desire for shared decision-making (SDM) about post-treatment surveillance, participants experienced no SDM. Information provision was often suboptimal and unstructured. Participants were open for using risk information in decision-making, but hesitant towards less intensive surveillance. Perceived advantages of less intensive surveillance were: less distressing moments, leaving the patient role behind, and lower burden. Disadvantages were: fewer moments for reassurance, fear of missing recurrences, and a higher threshold for aftercare for side effects. Conclusions SDM about post-treatment surveillance is desirable. Although women are hesitant about less intensive surveillance, they are open to the use of personalised risk assessment for recurrences in decision-making about surveillance. Implications for Cancer Survivors To facilitate SDM about post-treatment surveillance, the timing and content of information provision should be improved. Risk information should be provided in an accessible and understandable way. Moreover, fear of cancer recurrence and other personal considerations should be addressed in the process of SDM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available